DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/36vxhv/insomnia_pipeline) has announced the addition of the "Insomnia Pipeline Highlights - 2015" report to their offering.
The latest report, Insomnia Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global Insomnia market. It covers emerging therapies for Insomnia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Insomnia pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Insomnia pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Insomnia pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Insomnia pipeline products will be launched in the US and Ex-US till 2017.
Key Topics Covered:
1. Insomnia Pipeline by Stages
2. Insomnia Pipeline by Drug Class
3. Insomnia Pipeline by Company
4. Insomnia Phase 3 Clinical Trial Insights
5. Insomnia Phase 2 Clinical Trial Insights
6. Insomnia Phase 1 Clinical Trial Insights
7. Insomnia Preclinical Research Insights
8. Insomnia Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/36vxhv/insomnia_pipeline